| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | XENON PHARMACEUTICALS INC | 8,293 | 33,000 | 0.01% | ||
| 2 | MEI PHARMA INC | 580,401 | 940,000 | 0.20% | ||
| 3 | KALVISTA PHARMACEUTICALS INC | 329,942 | 2,577,000 | 0.55% | ||
| 4 | INVUITY INC | 1,080,272 | 8,588,000 | 1.83% | ||
| 5 | PARATEK PHARMACEUTICALS INC | 512,366 | 9,863,000 | 2.10% | ||
| 6 | APPLIED GENETIC TECHNOL CORP | 1,452,216 | 10,021,000 | 2.13% | ||
| 7 | CIDARA THERAPEUTICS INC | 1,356,813 | 10,583,000 | 2.25% | ||
| 8 | EIGER BIOPHARMACEUTICALS INC | 1,599,592 | 18,315,000 | 3.89% | ||
| 9 | MACROGENICS INC | 1,074,316 | 19,983,000 | 4.25% | ||
| 10 | OBALON THERAPEUTICS INC | 2,453,338 | 26,226,000 | 5.58% | ||
| 11 | GLAUKOS CORP | 1,018,362 | 52,242,000 | 11.11% | ||
| 12 | TESARO INCORPORATED | 2,021,403 | 311,033,000 | 66.12% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000950123-17-003458, filed 2017.04.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
